Sistema announces financial results for the first quarter 2022

Moscow, Russia – 9 June 2022 – Sistema PJSFC (“Sistema”, the “Corporation”, or together with its subsidiaries and affiliates the “Group”) (LSE: SSA, MOEX: AFKS), a Russian publicly traded investment company, announces its unaudited consolidated financial results in accordance with International Financial Reporting Standards (IFRS) for the first quarter of 2022 (1Q 2022) ending 31 March 2022.


  • Consolidated revenue grew by 26.2% year-on-year to RUB 216.4 billion.

  • Adjusted OIBDA increased by 22.0% year-on-year to RUB 69.4 billion.

  • Adjusted OIBDA margin was 32.1%.


  • High level of dividend income. In May 2022, the Board of Directors of MTS recommended that the Annual General Meeting of Shareholders approve a dividend payout for 2021 in the amount of RUB 66.3 billion.

  • In January 2022, Sistema received interim dividends from Segezha Group for 9М 2021 in the amount of RUB 4.1 billion. In May 2022, the General Meeting of Shareholders of Segezha Group approved final dividends for 2021 in the amount of RUB 10.0 billion.

  • Increased stake in the real-estate business. In May 2022, Sistema increased its effective share in Etalon Group to 48.8% with the acquisition of 72.9 million global depositary receipts for RUB 4.5 billion.

  • Continuation of foreign listing. In May 2022, Sistema received permission to continue trading in its depositary receipts outside Russia until 13 May 2023.

In 1Q 2022, Sistema’s consolidated revenue increased by 26.2% year-on-year to RUB 216.4 billion, driven by revenue growth at key assets: at MTS, thanks to higher revenues from telecommunication services and the development of smart targeted advertising services; at Segezha Group, due to higher sales volumes, positive pricing dynamics for key products, a positive impact from ruble depreciation as well as the consolidation of assets acquired in 2021; at Steppe, primarily due to an increase in milk production and sales as well as the aggressive development of niche crops trading; at Medsi, due to increased patient flows, the opening of new clinics and revenue from clinics acquired in late 2021. The consolidation of Binnopharm Group’s results in Sistema’s financial statements from 25 June 2021 also had an impact on the Corporation’s revenue.

The Group’s adjusted OIBDA increased by 22.0% year-on-year to RUB 69.4 billion in 1Q 2022 primarily as a result of higher adjusted OIBDA at subsidiaries: at MTS, following revenue growth in the telecom segment, higher margins and optimisation of retail network expenses; at Segezha Group, due to a considerable increase in revenue as well as improvements in operational and production efficiency; at Steppe, mainly as a result of effective sales of surpluses from the previous season’s record harvest and improved performance in trading operations and in the Dairy segment.

Group SG&A expenses rose 28.2% year-on-year in 1Q 2022, mainly on the back of an increase in SG&A at MTS, Segezha Group and Steppe, as well as the consolidation of Binnopharm Group’s results. SG&A at MTS increased as a result of accruals under the updated options programme for management and increased advertising expenses to develop the fintech segment and other ecosystem products. SG&A at Segezha Group increased as a result of revenue growth, as well as the consolidation of the assets of the Novoeniseisk Wood-Chemical Complex and Inter Forest Rus. The increase in SG&A at Steppe was mainly due to accruals under the LTI programme.

Group capex increased by 38.5% to RUB 52.3 billion in 1Q 2022 mainly due to increased investments in telecom and IT equipment at MTS.

Download press release

For further information, please visit or contact:

Investor Relations

Public Relations

Sergei Levitskiy

Sergei Kopytov

Tel: +7 (495) 730 66 00

Tel.: +7 (495) 730 17 05

Sistema PJSFC is a publicly traded diversified Russian holding company in the sectors of telecommunications, high technology, financial services, retail, paper and packaging, agriculture, real estate, tourism and medical services. The company was founded in 1993. Revenue in 2021 was RUB 802.4 billion; total assets equalled RUB 1.8 trillion as of 31 December 2021. Sistema's global depositary receipts are listed under the "SSA" ticker on the London Stock Exchange. Sistema's ordinary shares are listed under the "AFKS" ticker on the Moscow Exchange. Website:

The Company is not an investment company, and is not and will not be registered as such, under the U.S. Investment Company Act of 1940. Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of Sistema. You can identify forward looking statements by terms such as "expect,” "believe,” "anticipate,” "estimate,” "intend,” "will,” “could,” "may" or "might" the negative of such terms or other similar expressions. We wish to caution you that these statements are only predictions and that actual events or results may differ materially. We do not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, general economic conditions, our competitive environment, risks associated with the deterioration of the geopolitical situation, as well as many other risks specifically related to Sistema and its operations.

Sistema Group completes acquisition of hotel business from Wenaas Hotel Russia
9 March 2023
Sistema Group to double its hospitality business
1 February 2023
Sistema announces financial results for the third quarter 2022
15 December 2022
Sistema presents first-ever ESG strategy
20 October 2022


Selected category
By clicking on the «Subscribe» button, you agree to the personal data processing policy.